Author:
Mijiti Mutibaier,Wang Chun,Tian Wenxin,Shi Qiping,Zhang Fang,Abulaiti Renaguli,Qi Xiaolong,Kou Zhen,Liu Cuicui,Wang Zengsheng,Zhai Shunsheng,An Li,Huang Qin,Shao Yang,Wufuer Guzailinuer,Li Yan
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Sehn LH, Salles G (2021) Diffuse Large B-Cell Lymphoma. N Engl J Med 384(9):842–858. https://doi.org/10.1056/NEJMra2027612
2. Li X-Q, Li G-D, Gao Z, Zhou X, Zhu X (2012) Distribution pattern of lymphoma subtypes in China: a nationwide multicenter study of 10002 cases. J Diagn Concepts Pract 11(2):111–115
3. Matthews JM, Bhatt S, Patricelli MP, Nomanbhoy TK, Jiang X, Natkunam Y, Gentles AJ, Martinez E, Zhu D, Chapman JR (2016) Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma. Blood J Am Soc Hematol 128(2):239–248
4. Xu W, Liang J (2020) Advances in novel genotyping and molecular targeting therapy for diffuse large B cell lymphoma. J Clin Hematol 33(9):594–598
5. Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg M-L (2017) Genetic and functional drivers of diffuse large B cell lymphoma. Cell 171(2):481-494.e415